High expression of transcription factors FOXM1, MYBL2, and UBE2C (Fig. S3A, C, E) was associated with better survival in colon cancer patients, yet showed the opposite effect in stomach and lung cancers (Fig. S3B, D, F), aligning with our findings. Here, UBE2C is linked to lung cancer.